Zobrazeno 1 - 10
of 24
pro vyhledávání: '"BK Smruti"'
Autor:
Nag Shona, Chatterjee Sanjoy, Swarup Binay, RR Rao, Kukreja Anil, Aggarwal Shyam, Nigade Jagdish, Bhattacharya Priyanka, Prasad Krishna, Warrier Arun, Patil Poonam, Suresh H. Advani, BK Smruti, Singh Randeep, Singhal Manish, Raju Titus Chacko, SS Alurkar, TP Sahoo, Srinivasan Sankar, Keechilat Pavithran, Singh Ashish, Rajendranath Rejiv, Goswami Chanchal, Agarwal Amit, Agarwal Vijay, Desai Chirag, Gupta Sudeep
Publikováno v:
Indian Journal of Medical and Paediatric Oncology. 39:368-379
Human epidermal growth factor receptor 2 (HER2)-positive is an aggressive subtype of breast cancer and has historically been associated with poor outcomes. The availability of various anti-HER2 therapies, including trastuzumab, lapatinib, pertuzumab,
Publikováno v:
Neurology India. 57(6)
Background : Primary central nervous system (CNS) lymphoma (PCNSL) is a rare malignant non-Hodgkin's lymphoma and it accounts for 1% of all intracranial tumors. Only a few PCNSL studies have been reported from India, and studies on prognostic factors
Autor:
BK Smruti
Publikováno v:
Practical Gastroenterology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38378935fa4f6864bfaea03d341fa6e6
https://doi.org/10.5005/jp/books/10649_14
https://doi.org/10.5005/jp/books/10649_14
Publikováno v:
Gynecological Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88d75d78b3ff927138e6a4bb8a21f1c2
https://doi.org/10.5005/jp/books/10333_21
https://doi.org/10.5005/jp/books/10333_21
Autor:
Padhy Bimal Prasad, Satish V Khadilkar, AH Harish, Girish Muzumdar, BK Smruti, Jaggi T. Sunila, CE Devpujari
Publikováno v:
Annals of Indian Academy of Neurology
Annals of Indian Academy of Neurology, Vol 15, Iss 2, Pp 96-100 (2012)
Annals of Indian Academy of Neurology, Vol 15, Iss 2, Pp 96-100 (2012)
Autor:
PM Parikh, S Gupta, B Parikh, BK Smruti, J Issrani, S Topiwala, C Goswami, GS Bhattacharya, T Sen, JS Sekhon, H Malhotra, S Nag, RT Chacko, KBabu Govind, T Raja, AK Vaid, DC Doval, PK Das
Publikováno v:
Indian Journal of Cancer. 48:158
Background: In order to document the understanding of current evidence for the management of triple negative breast cancer and application of this knowledge in daily practice, we conducted an interactive survey of practicing Indian oncologists. Mater
Autor:
Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea. Electronic address: moisa@snu.ac.kr., Gennari A; Department of Translational Medicine, University Piemonte Orientale, Novara, Italy., Park YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim JH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Jiang ZF; Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China., Gupta S; Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India., Fadjari TH; Department of Internal Medicine, Hasan Sadikin General Hospital, Bandung, Indonesia., Tamura K; Department of Medical Oncology, Shimane University Hospital, Shimane, Japan., Mastura MY; Cancer Centre, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Abesamis-Tiambeng MLT; Section of Medical Oncology, Department of Internal Medicine, Cardinal Santos Cancer Center, San Juan, The Philippines., Lim EH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Lin CH; Department of Medical Oncology, National Taiwan University Hospital, Cancer Center Branch, Taipei, Taiwan., Sookprasert A; Department of Internal Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Parinyanitikul N; Medical Oncology Unit, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand., Tseng LM; Taipei-Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, Singapore., Caguioa P; The Cancer Institute of St Luke's Medical Center, National Capital Region, The Philippines; The Cancer Institute of the University of Santo Tomas Hospital, National Capital Region, The Philippines., Singh M; Department of Radiotherapy, Pantai Cancer Institute, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; Department of Oncology, Pantai Cancer Institute, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Naito Y; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan., Hukom RA; Department of Hematology and Medical Oncology, Dharmais Hospital (National Cancer Center), Jakarta, Indonesia., Smruti BK; Medical Oncology, Lilavati Hospital and Research Centre and Bombay Hospital Institute of Medical Sciences, Mumbai, India., Wang SS; Cancer Center, Sun Yat-sen University, Guangzhou, China., Kim SB; Department of Oncology, Asan Medical Centre, Seoul, Republic of Korea., Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea., Ahn HK; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea., Peters S; Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Kim TW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Pentheroudakis G; ESMO, Lugano, Switzerland., Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan, Italy; Department of Oncology and Haematology, University of Milano, Milan, Italy., Harbeck N; Breast Center, Department of Obstetrics and Gynaecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.
Publikováno v:
ESMO open [ESMO Open] 2023 Jun; Vol. 8 (3), pp. 101541. Date of Electronic Publication: 2023 May 11.
Autor:
Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: tyoshino@east.ncc.go.jp., Argilés G; Luis Diaz Laboratory, MSKCC, Sloan Kettering Institute, New York, USA., Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Martinelli E; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy., Taniguchi H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Arnold D; Asklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany., Mishima S; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Li Y; Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Smruti BK; Department of Medical Oncology, Lilavati Hospital and Research Centre and Bombay Hospital, Mumbai, India., Ahn JB; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Seoul, Korea., Faud I; Department of Radiotherapy & Oncology, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia., Chee CE; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Yeh KH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Lin PC; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chua C; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore., Hasbullah HH; Oncology Unit, Faculty of Medicine, UiTM Sg Buloh, Selangor, Malaysia., Lee MA; Division of Medical Oncology, Department of Internal Medicine, Cancer Research Institute, College of Medicine, St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea., Sharma A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India., Sun Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Curigliano G; Istituto Europeo di Oncologia, IRCCS and University of Milano, Milan, Italy., Bando H; Department of Clinical Oncology, Aichi Cancer Center, Nagoya, Japan., Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology, and Infectious Diseases, University Cancer Center, Leipzig University Medical Center, Leipzig, Germany., Yamanaka T; Department of Biostatistics, Yokohama City University, Kanagawa, Japan., Tabernero J; Department of Medical Oncology, Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain., Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Cervantes A; CIBERONC, Department of Medical Oncology, Institute of Health Research, INCLIVIA, University of Valencia, Valencia, Spain., Ohtsu A; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Peters S; Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Ishioka C; Department of Clinical Oncology, Tohoku University School of Medicine, Sendai, Japan., Pentheroudakis G; ESMO, Lugano, Switzerland.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Dec; Vol. 32 (12), pp. 1496-1510. Date of Electronic Publication: 2021 Aug 16.
Autor:
Moreker MR; Department of Ophthalmology, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India., Dudani AI; Department of Ophthalmology, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India., Sharma TR; Department of Ophthalmology, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India., Patel K; Department of Pathology, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India., Smruti BK; Department of Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India.
Publikováno v:
Indian journal of ophthalmology [Indian J Ophthalmol] 2020 Sep; Vol. 68 (9), pp. 2054-2056.
Autor:
Malhotra H; Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India., Kowtal P; Sarin Laboratory and OIC Sanger Sequencing Facility, Advanced Centre for Treatment Research, and Education in Cancer, Navi Mumbai, India., Mehra N; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India., Pramank R; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India., Sarin R; Radiation Oncology, Cancer Genetics Unit, Tata Memorial Centre and PI Sarin Laboratory, Advanced Centre for Treatment Research and Education in Cancer, Navi Mumbai, India., Rajkumar T; Department of Molecular Oncology, Cancer Institute (WIA), Chennai, India., Gupta S; Tata Memorial Centre Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, India., Bapna A; Department of Medical Oncology, Bhagwan Mahavir Cancer Hospital Research Center, Jaipur, India., Bhattacharyya GS; Fortis Hospital, Kolkata, India., Gupta S; Department of Gynae Oncology, Medanta-The Medicity, Gurgaon, India., Maheshwari A; Department of Gynecologic Oncology, Tata Memorial Centre, Mumbai, India., Mannan AU; Clinical Diagnostics, Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Bangalore, India., Reddy Kundur R; Cancer Genetics Clinic, Tata Memorial Centre, Mumbai, India., Sekhon R; Gynae Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India., Singhal M; Medical Oncology, Apollo Hospital, New Delhi, India., Smruti BK; Bombay Hospital and Medical Research Centre, Mumbai, India., Sp S; Manipal Comprehensive Cancer Center, Manipal Hospital, Bengaluru, India., Suryavanshi M; Molecular Diagnostics, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India., Verma A; Molecular Oncology and Cancer Genetics, Max Hospital, New Delhi, India.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2020 Jul; Vol. 6, pp. 991-1008.